WAM
CTOR

Weiss Asset Management’s Citius Oncology CTOR Stock Holding History

Weiss Asset Management’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-350,000
Closed -$3.64M – 325
2023
Q1 		$3.64M Hold
350,000
– – 0.23% 96
2022
Q4 		$3.56M Buy
+350,000
New +$3.55M 0.14% 177

Other funds holding CTOR

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Weiss Asset Management's CTOR Position: Q2 2023 in Review

Weiss Asset Management sold out of Citius Oncology (CTOR) in Q2 2023, closing a stake of 350,000 shares — an estimated $3.64M sold.

Weiss Asset Management first reported a position in CTOR in Q4 2022 and held it in 2 quarters. The position peaked at $3.64M in Q1 2023. 22 funds tracked by Wall St. Rank hold CTOR as of Q2 2023.

  • Weiss Asset Management reported no remaining Citius Oncology position as of Q2 2023 after selling out during the quarter.
  • Weiss Asset Management sold 350,000 Citius Oncology shares in Q2 2023, an estimated $3.64M.
  • Weiss Asset Management first reported a position in Citius Oncology in Q4 2022 and held it in 2 quarters.
  • Weiss Asset Management's Citius Oncology position peaked at $3.64M in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2023.

Based on Weiss Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.